Impact of low and high body mass index on predicting therapeutic efficacy and prognosis in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.
International journal of urology : official journal of the Japanese Urological Association（2023）
摘要
We showed the impact of both low and high BMI on predicting therapeutic efficacy and prognosis in mRCC patients treated with TKI.
更多查看译文
关键词
body mass index,first-line tyrosine kinase inhibitors,metastatic renal cell carcinoma,prognostic marker
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要